Clinically, serum adiponectin concentrations are also inversely related to the risk of developing type II diabetes and cardiovascular disease, but directly related to decompensated congestive heart failure (CHF) [1,8,9,10,11,12,13]. This evidence concerns the gene ADIPOQ and congestive heart failure.